Why Do Stocks With Better Fundamentals Trail Their Peers? And When Should You Accept Waiting for a Re-Rating Is a Lost Cause?

Stocks with better fundamentals trail their peers - that's just the reality of the market. But why? What are the Best ASX Stocks to invest in right now? Check our buy/sell…

ByNick Sundich

10

Mar 2026

Healthcare Stocks

Pro Medicus (ASX: PME) Falls Despite A$40m in US Renewals: Is This a Buying Opportunity?

Pro Medicus Dips Despite Strong Renewals Pro Medicus (ASX: PME) slipped around 1% on Monday despite announcing approximately A$40m in US contract renewals, including an expanded deal with MedStar Health…

ByUjjwal Maheshwari

23

Feb 2026

Blue Chip Stocks

Here are 6 of the best results this ASX reporting season (so far), and 6 of the worst!

This article recaps some of the best results this ASX reporting season so far, as well as some of the worst - 6 of each to be exact. We are looking…

ByNick Sundich

14

Feb 2026

Healthcare Stocks

Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy

ASX healthcare stocks are crashing- which one is worth buying now? Three of Australia's most premium ASX healthcare stocks have been crushed in the same week. CSL (ASX: CSL) has…

ByUjjwal Maheshwari

12

Feb 2026

Healthcare Stocks

Pro Medicus (ASX:PME) Down 16% on a Great Result, Here’s Why

A Premium Multiple Leaves No Room for “Good” Pro Medicus fell 16% despite what, on the surface, looked like an exceptional half yearly result. A lot of investors will be…

ByCharlie Youlden

23

Dec 2025

Healthcare Stocks

Is Pro Medicus (ASX:PME) a Buy After the 34% Pullback?

Pro Medicus slips, growth momentum remains Pro Medicus (ASX: PME) has dropped approximately 34% from its record high of A$336 in July 2025 and now trades near A$222. Investors are…

ByUjjwal Maheshwari

02

Sep 2025

Healthcare Stocks Life Sciences

4D Medical (ASX:4DX) could become the next Pro Medicus, and its taken some important strides in 2025!

There's not many Australian radiology companies that seek to conquer the USA, but 4D Medical (ASX:4DX) is one of them. Another one was Pro Medicus (ASX:PME), and everyone knows how…

ByNick Sundich

02

Sep 2025

Bank Stocks Basic Materials Blue Chip Stocks Consumer Copper Stocks Dividend Stocks Energy Stocks ETF Financials Gold Stocks Healthcare Stocks Industrials Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Mining Stocks Penny Stocks Property Rare Earths Stocks Resources Retail Semiconductor stocks Small Caps Stocks Tech Stocks Technology Uranium Stocks

ASX stocks in America: Here are 4 performing well and 4 performing poorly

You might think ASX stocks in America are doing better than peers which are not there because the USA is a much bigger market. In reality, this is not always…

ByNick Sundich

25

Aug 2025

Healthcare Stocks

4 reasons why Pro Medicus (ASX:PME) just keeps rising to new heights

Another reporting season, another impressive result from Pro Medicus (ASX:PME). Eerily similar to the debate going on about CBA (ASX:CBA), investors debate about whether or not it is overvalued or …

ByNick Sundich

18

Aug 2025

Healthcare Stocks International Stocks

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

What does the next few years hold for ASX Health Care Stocks Under Trump? There's no doubt that the health care sector is bearing a greater brunt than any other…

ByNick Sundich

Why Do Stocks With Better Fundamentals Trail Their Peers? And When Should You Accept Waiting for a Re-Rating Is a Lost Cause?

Pro Medicus (ASX: PME) Falls Despite A$40m in US Renewals: Is This a Buying Opportunity?

Here are 6 of the best results this ASX reporting season (so far), and 6 of the worst!

Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy

Pro Medicus (ASX:PME) Down 16% on a Great Result, Here’s Why

Is Pro Medicus (ASX:PME) a Buy After the 34% Pullback?

4D Medical (ASX:4DX) could become the next Pro Medicus, and its taken some important strides in 2025!

ASX stocks in America: Here are 4 performing well and 4 performing poorly

4 reasons why Pro Medicus (ASX:PME) just keeps rising to new heights

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Stocks in Spotlight

Add Your Heading Text Here